EV/EBITDA
0.03
+0.04+400.00%
20 min ago
Summary:
GT Biopharma EV/EBITDA is currently 0.03, with a rise of +0.04 (+400.00%) during the most recent trading day. Over the past year, it has increased by +0.74 (+104.23%). GTBP EV/EBITDA is now -93.18% below its all-time high of 0.44.GTBP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +400.0% |
| 1 m1 month | +200.0% |
| 3 m3 months | -92.5% |
| 6 m6 months | +105.2% |
| ytdytd | +102.3% |
| 1 y1 year | +104.2% |
| 5 y5 years | +105.6% |
GTBP EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.03 | at high | -0.10 | +130.0% |
| 3 m | 3 months | 0.44 | -93.2% | -0.10 | +130.0% |
| 6 m | 6 months | 0.44 | -93.2% | -0.59 | +105.1% |
| 1 y | 1 year | 0.44 | -93.2% | -1.30 | +102.3% |
| 3 y | 3 years | 0.44 | -93.2% | -2.88 | +101.0% |
| 5 y | 5 years | 0.44 | -93.2% | -9.66 | +100.3% |
| alltime | all time | 0.44 | -93.2% | -9.66 | +100.3% |
GT Biopharma EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 0.03(-102.3%) |
| 2023 | -1.29(+14.2%) |
| 2022 | -1.13(-27.1%) |
| Date | Value |
|---|---|
| 2021 | -1.55(-34.0%) |
| 2020 | -2.35(+351.9%) |
| 2019 | -0.52(+205.9%) |
| 2018 | -0.17 |
FAQ
- What is GT Biopharma EV/EBITDA?
- What is the all time high EV/EBITDA for GT Biopharma?
- What is GTBP EV/EBITDA year-to-date change?
- What is GT Biopharma EV/EBITDA year-on-year change?
What is GT Biopharma EV/EBITDA?
The current EV/EBITDA of GTBP is 0.03
What is the all time high EV/EBITDA for GT Biopharma?
GT Biopharma all-time high EV/EBITDA is 0.44
What is GTBP EV/EBITDA year-to-date change?
GT Biopharma EV/EBITDA has changed by +1.32 (+102.33%) since the beginning of the year
What is GT Biopharma EV/EBITDA year-on-year change?
Over the past year, GTBP EV/EBITDA has changed by +0.74 (+104.23%)